CA2253769C - Composes pharmaceutiques a base de fenofibrate - Google Patents

Composes pharmaceutiques a base de fenofibrate Download PDF

Info

Publication number
CA2253769C
CA2253769C CA 2253769 CA2253769A CA2253769C CA 2253769 C CA2253769 C CA 2253769C CA 2253769 CA2253769 CA 2253769 CA 2253769 A CA2253769 A CA 2253769A CA 2253769 C CA2253769 C CA 2253769C
Authority
CA
Canada
Prior art keywords
water
precipitate
fenofibrate
soluble excipient
solvents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2253769
Other languages
English (en)
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2253769 priority Critical patent/CA2253769C/fr
Application granted granted Critical
Publication of CA2253769C publication Critical patent/CA2253769C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
CA 2253769 1998-11-10 1998-11-10 Composes pharmaceutiques a base de fenofibrate Expired - Fee Related CA2253769C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2253769 CA2253769C (fr) 1998-11-10 1998-11-10 Composes pharmaceutiques a base de fenofibrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2253769 CA2253769C (fr) 1998-11-10 1998-11-10 Composes pharmaceutiques a base de fenofibrate

Publications (1)

Publication Number Publication Date
CA2253769C true CA2253769C (fr) 2000-09-26

Family

ID=29425633

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2253769 Expired - Fee Related CA2253769C (fr) 1998-11-10 1998-11-10 Composes pharmaceutiques a base de fenofibrate

Country Status (1)

Country Link
CA (1) CA2253769C (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034908A2 (fr) * 2003-10-10 2005-04-21 Lifecycle Pharma A/S Forme posologique solide comprenant une fibrate et une statine
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7658944B2 (en) 2003-10-10 2010-02-09 Lifecycle Pharma A/S Solid dosage form comprising a fibrate
US7732413B2 (en) 2003-03-07 2010-06-08 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7741289B2 (en) 2003-03-07 2010-06-22 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US8062664B2 (en) * 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7732413B2 (en) 2003-03-07 2010-06-08 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7741289B2 (en) 2003-03-07 2010-06-22 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2005034908A2 (fr) * 2003-10-10 2005-04-21 Lifecycle Pharma A/S Forme posologique solide comprenant une fibrate et une statine
WO2005034908A3 (fr) * 2003-10-10 2005-08-11 Lifecycle Pharma As Forme posologique solide comprenant une fibrate et une statine
US7658944B2 (en) 2003-10-10 2010-02-09 Lifecycle Pharma A/S Solid dosage form comprising a fibrate
US8124125B2 (en) 2003-10-10 2012-02-28 Veloxis Pharmaceuticals A/S Solid dosage form comprising a fibrate
US8481078B2 (en) 2003-10-10 2013-07-09 Veloxis Pharmaceuticals A/S Solid dosage form comprising a fibrate
US8062664B2 (en) * 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs

Similar Documents

Publication Publication Date Title
US6511681B2 (en) Aqueous solubility pharmaceutical formulations
RU2351316C2 (ru) Лекарственные формы с замедленным высвобождением зипразидона
EP1039909B1 (fr) Procede de preparation et composition d'une preparation orale d'itraconazole
JP2002523443A (ja) オメプラゾール製剤
WO2000024423A1 (fr) Particules a liberation prolongee
EP0630233A1 (fr) Composition pour preparations buvables.
HU226492B1 (en) Enteric coated pharmaceutical tablet containing didanoside
JP2008540644A (ja) 新規粒質化方法及びそれから生成される粒質物
WO2008077591A2 (fr) Dispersion solide d'un antagoniste de la neurokinine
WO2005077342A1 (fr) Microcomprimes de lansoprazole gastroresistants
SK7162001A3 (en) Compositions comprising cefuroxime axetil
JP2000514057A (ja) 増強されたバイオアベイラビリティを有する抗真菌剤の固溶体
US20100204292A1 (en) Pharmaceutical compositions comprising intra-and extra-granular fractions
JP2004525887A (ja) 新規フェノフィブラート錠剤
CA2253769C (fr) Composes pharmaceutiques a base de fenofibrate
US20110311625A1 (en) Solid dosage forms of fenofibrate
US20020028248A1 (en) Rapid-release microdispersible ecadotril preparation
US20030096014A1 (en) Solid pharmaceutical compositions for oral administration comprising itraconazole
US8062664B2 (en) Process for preparing formulations of lipid-regulating drugs
JPH08291063A (ja) 易吸収性製剤及びその製造法
WO2009034409A2 (fr) Compositions pharmaceutiques de rheine ou de diacereine
KR100981751B1 (ko) 프란루카스트를 함유하는 과립 및 그의 제조방법
JPH05139973A (ja) ニフエジピン含有固形製剤の製造方法
US20220241230A1 (en) Diclofenac sachet composition
JP2813792B2 (ja) マレイン酸イルソグラジン経口投与用製剤およびその製造法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed